This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Brain Glioblastoma
and you are
over 19
years old
0
This is an early phase trial to investigate
how or whether the drug affects your body.
Show me locations

The purpose

This early phase I trial studies the how well fluorodeoxyglucose F-18 (FDG) positron emission tomography (PET) imaging works in diagnosing patients with confirmed or suspected glioblastoma. Diagnostic procedures, such as FDG PET, may help find and diagnose glioblastoma.

Provided treatments

  • Procedure: Computed Tomography
  • Radiation: Fludeoxyglucose F-18
  • Procedure: Magnetic Resonance Imaging
  • Procedure: Positron Emission Tomography

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02885272. The sponsor of the trial is M.D. Anderson Cancer Center and it is looking for 20 volunteers for the current phase.
Official trial title:
Dual Time Point FDG PET Imaging Optimization for the Evaluation of Glioblastoma